» Authors » K McAdam

K McAdam

Explore the profile of K McAdam including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 572
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Margham J, McAdam K, Cunningham A, Porter A, Fiebelkorn S, Mariner D, et al.
Front Chem . 2021 Oct; 9:743060. PMID: 34660535
As e-cigarette popularity has increased, there is growing evidence to suggest that while they are highly likely to be considerably less harmful than cigarettes, their use is not free of...
2.
Favara D, McAdam K, Cooke A, Bordessa-Kelly A, Budriunaite I, Bossingham S, et al.
Clin Oncol (R Coll Radiol) . 2021 May; 33(10):667-675. PMID: 33941453
Aims: The proportion of UK oncology healthcare professionals (HCPs) infected with SARS-CoV-2 during the COVID-19 pandemic's first wave is unknown. The primary aim of this study was to determine the...
3.
Favara D, Cooke A, Doffinger R, McAdam K, Corrie P, Ainsworth N
Clin Oncol (R Coll Radiol) . 2020 Aug; 33(1):e61-e63. PMID: 32732111
No abstract available.
4.
Earl H, Hiller L, Dunn J, Macpherson I, Rea D, Hughes-Davies L, et al.
Clin Oncol (R Coll Radiol) . 2020 Jul; 33(1):15-19. PMID: 32723485
No abstract available.
5.
Corrie P, Qian W, Basu B, Valle J, Falk S, Lwuji C, et al.
Br J Cancer . 2020 May; 122(12):1760-1768. PMID: 32350413
Background: Nab-paclitaxel plus gemcitabine (nabP+gemcitabine) offers modest survival gains for patients with metastatic pancreatic ductal adenocarcinoma (PDAC). Sequential scheduling of nabP+gemcitabine in a PDAC mouse model improved efficacy; this hypothesis...
6.
McAdam K, Davis P, Ashmore L, Eaton D, Jakaj B, Eldridge A, et al.
Regul Toxicol Pharmacol . 2018 Nov; 101:156-165. PMID: 30445136
There is increasing diversity of nicotine inhalation products worldwide. Next Generation Products (NGP) such as e-cigarettes, have gained mass popularity, and there is increasing use of electrical and carbon-based Tobacco-Heating...
7.
McAdam K, Vas C, Kimpton H, Faizi A, Liu C, Porter A, et al.
Chem Cent J . 2018 Jul; 12(1):86. PMID: 30043180
Background: We are interested in comparing the levels of harmful or potentially harmful constituents in Swedish and American smokeless tobacco products (STPs). We report here the concentrations of the IARC...
8.
McAdam K, Kimpton H, Porter A, Liu C, Faizi A, Mola M, et al.
Chem Cent J . 2017 Dec; 11(1):131. PMID: 29256072
There is considerable interest in the chemical composition of smokeless tobacco products (STPs), owing to health concerns associated with their use. Previous studies have documented levels of Po, Pb and...
9.
Earl H, Hiller L, Dunn J, Blenkinsop C, Grybowicz L, Vallier A, et al.
Ann Oncol . 2017 May; 28(8):1817-1824. PMID: 28459938
Background: The ARTemis trial previously reported that addition of neoadjuvant bevacizumab (Bev) to docetaxel (D) followed by fluorouracil, epirubicin and cyclophosphamide (D-FEC) in HER2 negative breast cancer improved the pathological...
10.
Hertz-Schunemann R, Ehlert S, Streibel T, Liu C, McAdam K, Baker R, et al.
Anal Bioanal Chem . 2015 Jan; 407(8):2293-9. PMID: 25627787
The time- and space-resolved chemical signatures of gases and vapours formed in solid-state combustion processes are difficult to examine using recent analytical techniques. A machine-smoked cigarette represents a very reproducible...